Dianthus Therapeutics, Inc. (DNTH)
USD 15.63
(-7.9%)
USD 15.63
(-7.9%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -131.73 Million USD | -803.75% |
| 2022 | -14.57 Million USD | -90.85% |
| 2021 | -7.63 Million USD | 86.87% |
| 2020 | -58.15 Million USD | 10.63% |
| 2019 | -65.07 Million USD | -11.53% |
| 2018 | -58.34 Million USD | -13.14% |
| 2017 | -51.56 Million USD | -1035.09% |
| 2016 | -4.54 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -313.76 Million USD | 4.7% |
| 2024 Q1 | -329.22 Million USD | -149.91% |
| 2023 Q1 | -50.3 Million USD | -245.08% |
| 2023 FY | -131.73 Million USD | -803.75% |
| 2023 Q2 | -62.63 Million USD | -24.51% |
| 2023 Q3 | -156.61 Million USD | -150.05% |
| 2023 Q4 | -131.73 Million USD | 15.88% |
| 2022 Q2 | -23.22 Million USD | 41.08% |
| 2022 Q4 | -14.57 Million USD | 48.36% |
| 2022 Q1 | -39.41 Million USD | 70.06% |
| 2022 FY | -14.57 Million USD | -90.85% |
| 2022 Q3 | -28.23 Million USD | -21.57% |
| 2021 Q2 | -155.03 Million USD | -214.54% |
| 2021 FY | -7.63 Million USD | 86.87% |
| 2021 Q1 | -49.28 Million USD | 15.24% |
| 2021 Q4 | -131.65 Million USD | 16.43% |
| 2021 Q3 | -157.53 Million USD | -1.62% |
| 2020 FY | -58.15 Million USD | 10.63% |
| 2020 Q3 | -141.68 Million USD | -3.96% |
| 2020 Q1 | -74.93 Million USD | -15.16% |
| 2020 Q2 | -136.28 Million USD | -81.88% |
| 2020 Q4 | -58.15 Million USD | 58.96% |
| 2019 Q4 | -65.07 Million USD | 23.9% |
| 2019 FY | -65.07 Million USD | -11.53% |
| 2019 Q3 | -85.5 Million USD | -158.24% |
| 2019 Q2 | -33.11 Million USD | -5.99% |
| 2019 Q1 | -31.24 Million USD | 46.45% |
| 2018 Q3 | -159.67 Million USD | 7.93% |
| 2018 FY | -58.34 Million USD | -13.14% |
| 2018 Q2 | -173.42 Million USD | -318.28% |
| 2018 Q1 | -41.46 Million USD | 19.34% |
| 2018 Q4 | -58.34 Million USD | 63.46% |
| 2017 Q4 | -51.4 Million USD | 0.0% |
| 2017 FY | -51.56 Million USD | -1035.09% |
| 2016 FY | -4.54 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -135.502% |
| Alkermes plc | -166.73 Million USD | 20.99% |
| Agenus Inc. | 274.13 Million USD | 148.056% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 107.045% |
| Aptorum Group Limited | 1.35 Million USD | 9807.851% |
| Ardelyx, Inc. | 34.51 Million USD | 481.722% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 3178.037% |
| Bicycle Therapeutics plc | -481.46 Million USD | 72.638% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 464.295% |
| ChromaDex Corporation | -24.04 Million USD | -447.821% |
| Chimerix, Inc. | -25.51 Million USD | -416.283% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 1990.622% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -456.405% |
| CRISPR Therapeutics AG | -150.84 Million USD | 12.665% |
| Precision BioSciences, Inc. | -85.41 Million USD | -54.244% |
| Dyadic International, Inc. | -6.37 Million USD | -1965.506% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -726.837% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1818.721% |
| Lantern Pharma Inc. | -21.7 Million USD | -507.005% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -19.182% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1442.049% |
| Incyte Corporation | -3.17 Billion USD | 95.851% |
| IO Biotech, Inc. | -140.69 Million USD | 6.367% |
| Jaguar Health, Inc. | 29.39 Million USD | 548.232% |
| Novavax, Inc. | -298.29 Million USD | 55.836% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 2568.428% |
| Opthea Limited | 28.15 Million USD | 567.869% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -684.68% |
| ContextLogic Inc. | -232 Million USD | 43.216% |
| MiMedx Group, Inc. | -33.9 Million USD | -288.602% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1392.202% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -5585.734% |
| NextCure, Inc. | -6.47 Million USD | -1933.966% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -160.866% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -1965.214% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1183.097% |
| Vaxcyte, Inc. | -368.22 Million USD | 64.223% |
| PDS Biotechnology Corporation | -32.7 Million USD | -302.765% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 862.473% |
| Pharming Group N.V. | 109.8 Million USD | 219.977% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -657.301% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 24.819% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -611.345% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -611.345% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -1755.493% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -2148.123% |
| Acelyrin, Inc. | -216.9 Million USD | 39.263% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -2248.195% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -7541.531% |
| Summit Therapeutics Inc. | 34.67 Million USD | 479.939% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -1836.499% |
| Senti Biosciences, Inc. | 1.74 Million USD | 7671.264% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 28.638% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -70.095% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -2073.21% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 132145.023% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 21077.707% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -12.554% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 21.692% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 218.824% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -1634.334% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -2.034% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2010.771% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 45.644% |
| Immix Biopharma, Inc. | -17.5 Million USD | -652.379% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 58.403% |
| MEI Pharma, Inc. | -3.7 Million USD | -3455.735% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1152.993% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 181.451% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 574.004% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1818.721% |
| Precigen, Inc. | -481 Thousand USD | -27288.773% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1035.587% |
| AlloVir, Inc. | -62.69 Million USD | -110.138% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -136.883% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 313.635% |
| ImmuCell Corporation | 10.99 Million USD | 1298.665% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 14.536% |
| Onconetix, Inc. | 5.33 Million USD | 2571.004% |
| PureTech Health plc | -167.19 Million USD | 21.207% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -332.502% |
| Elevation Oncology, Inc. | -19.11 Million USD | -589.089% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -2583.642% |
| Seer, Inc. | -4.24 Million USD | -3007.075% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -448.072% |
| Innoviva, Inc. | 255.56 Million USD | 151.549% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -135.823% |
| ESSA Pharma Inc. | -33.62 Million USD | -291.832% |
| GlycoMimetics, Inc. | -40.98 Million USD | -221.439% |
| GT Biopharma, Inc. | -1.02 Million USD | -12803.036% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -94.356% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 315.061% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 1.744% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -850.779% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -356.29% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -174774.557% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -326.868% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1507.594% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -4110.267% |
| Soligenix, Inc. | -4.95 Million USD | -2560.556% |
| Century Therapeutics, Inc. | 847 Thousand USD | 15653.719% |
| Kura Oncology, Inc. | -20.11 Million USD | -554.836% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -221.898% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1468.707% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 7331.726% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -4020.738% |
| Autolus Therapeutics plc | -186.59 Million USD | 29.399% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -167.199% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 52.232% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 484.44% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 180.149% |
| GRI Bio, Inc. | -1.79 Million USD | -7243.367% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1366.54% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -296.127% |
| IGM Biosciences, Inc. | -72.6 Million USD | -81.445% |
| INmune Bio, Inc. | -25.41 Million USD | -418.437% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 187.273% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -160.052% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -710.739% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -4466.495% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 446.547% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -219.874% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 513.172% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 134.856% |
| Verastem, Inc. | -37.27 Million USD | -253.399% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1352.0% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -154.02% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -770.433% |
| Histogen Inc. | -7.48 Million USD | -1659.583% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -509.715% |
| Surrozen, Inc. | -32.66 Million USD | -303.319% |
| Organovo Holdings, Inc. | -1.5 Million USD | -8641.871% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3034.064% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 794.824% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 5135.933% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 3269.875% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1471.861% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -203.255% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -803.761% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 58.414% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -18145.021% |
| Apollomics, Inc. | -27.39 Million USD | -380.891% |
| Amarin Corporation plc | -191.04 Million USD | 31.041% |
| Mesoblast Limited | 55.96 Million USD | 335.406% |
| Turnstone Biologics Corp. | -14.58 Million USD | -803.319% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -420.876% |
| Synaptogenix, Inc. | -28.66 Million USD | -359.641% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -13974.786% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 370.336% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -15181.485% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -1713.082% |
| Exelixis, Inc. | -73.05 Million USD | -80.342% |
| Better Therapeutics, Inc. | -860 Thousand USD | -15218.605% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -448.619% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 45.42% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 17997.851% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -1671.143% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 10605.582% |
| Gritstone bio, Inc. | 39.49 Million USD | 433.603% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -56.645% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -4905.053% |
| Avid Bioservices, Inc. | 169.72 Million USD | 177.618% |
| Insmed Incorporated | 721.62 Million USD | 118.256% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1341.118% |
| MediWound Ltd. | -5.32 Million USD | -2375.385% |
| OmniAb, Inc. | 9.2 Million USD | 1531.49% |
| Alector, Inc. | -35.63 Million USD | -269.672% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 253.238% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -2573.295% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1095.09% |
| Zai Lab Limited | -775 Million USD | 83.001% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 138.684% |
| Aura Biosciences, Inc. | -21.52 Million USD | -512.033% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -59.724% |
| Immunic, Inc. | -45.34 Million USD | -190.56% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 31.817% |
| Veracyte, Inc. | -203.82 Million USD | 35.366% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 120.639% |
| FibroGen, Inc. | 56.76 Million USD | 332.071% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1579.394% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -4559.928% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -6263.181% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 102.87% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -3843.131% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 20.621% |
| TG Therapeutics, Inc. | 17.86 Million USD | 837.543% |
| Galecto, Inc. | -21.21 Million USD | -520.946% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -453.878% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 108.394% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -438.33% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1044.868% |
| XBiotech Inc. | -200.02 Million USD | 34.138% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -56.645% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 3009.452% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -273.593% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -70.608% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 2414.883% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 22.695% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -42.616% |
| Vaxxinity, Inc. | 10.13 Million USD | 1400.237% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 117.893% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1123.491% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -99.739% |
| NexImmune, Inc. | -3.13 Million USD | -4104.053% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -3715.594% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -771.789% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -386.125% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1367.683% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -105651.554% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -224.707% |
| Ainos, Inc. | 4.07 Million USD | 3330.562% |
| Pluri Inc. | 22.82 Million USD | 677.073% |
| Prothena Corporation plc | -608.34 Million USD | 78.345% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -10.933% |
| Celularity Inc. | 65.19 Million USD | 302.086% |
| Rallybio Corporation | -24.1 Million USD | -446.594% |
| Cue Biopharma, Inc. | -33.81 Million USD | -289.544% |
| MeiraGTx Holdings plc | -40.3 Million USD | -226.882% |
| Omeros Corporation | 331.17 Million USD | 139.779% |
| Humacyte, Inc. | -22.48 Million USD | -485.876% |
| Immunocore Holdings plc | -358.59 Million USD | 63.262% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -436.073% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -326.329% |
| Blueprint Medicines Corporation | 702.83 Million USD | 118.744% |
| CalciMedica, Inc. | -5.53 Million USD | -2282.278% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 30.007% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1189.798% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -229.046% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -296.175% |
| Pulmatrix, Inc. | -10.41 Million USD | -1164.664% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -2104.116% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -245.394% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -18.256% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -119.772% |
| Cytokinetics, Incorporated | 642.37 Million USD | 120.508% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -2162.408% |
| Nutriband Inc. | -251.65 Thousand USD | -52249.03% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -286.119% |
| Vor Biopharma Inc. | 4.3 Million USD | 3163.721% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 97.817% |
| Evogene Ltd. | -19.63 Million USD | -570.979% |
| ProKidney Corp. | -56.23 Million USD | -134.263% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -170.669% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1326.192% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 109.659% |
| CorMedix Inc. | -43.05 Million USD | -205.998% |
| BioLineRx Ltd. | 7.33 Million USD | 1895.802% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -379.665% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 385.479% |
| Atai Life Sciences N.V. | -28.55 Million USD | -361.307% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 6006.222% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -477.402% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 842.825% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -75.48% |
| MediciNova, Inc. | -50.78 Million USD | -159.415% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -67.172% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -585541.249% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1941.661% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 34.071% |
| Biomea Fusion, Inc. | -166.57 Million USD | 20.91% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 26.392% |
| Mereo BioPharma Group plc | -51.46 Million USD | -155.96% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -38.902% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 55.154% |
| Absci Corporation | -72.59 Million USD | -81.465% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2985.239% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 43.806% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -39.835% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -37.665% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -237.164% |
| Allakos Inc. | -24.97 Million USD | -427.487% |
| Imunon, Inc. | -4.21 Million USD | -3026.356% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -793.637% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 2.703% |
| BioAtla, Inc. | -109.01 Million USD | -20.85% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 17997.851% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -13929.819% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1200.953% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -521.327% |
| XOMA Corporation | -29 Million USD | -354.276% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -695.531% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1361.18% |
| aTyr Pharma, Inc. | -7.44 Million USD | -1668.56% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -5.7% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 36.713% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -61.093% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -42.018% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -15233.153% |
| Akari Therapeutics, Plc | -3.84 Million USD | -3326.268% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 8217.617% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 109.54% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -10987.966% |
| UroGen Pharma Ltd. | 4.39 Million USD | 3100.228% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 216.09% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 183168.84% |
| Orgenesis Inc. | 21.78 Million USD | 704.756% |
| Entera Bio Ltd. | -10.62 Million USD | -1139.439% |
| GH Research PLC | -78.07 Million USD | -68.731% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -491.08% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -394.167% |
| Xencor, Inc. | 29.64 Million USD | 544.407% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -6587.948% |
| Replimune Group, Inc. | 1.41 Million USD | 9430.028% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -53691.627% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -4.211% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -10987.966% |
| Portage Biotech Inc. | -4.98 Million USD | -2544.85% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -585541.249% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -99.238% |
| OncoCyte Corporation | -6.56 Million USD | -1907.314% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 14779.974% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -2791.798% |
| Purple Biotech Ltd. | -14.13 Million USD | -831.815% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -454.555% |
| scPharmaceuticals Inc. | -6.54 Million USD | -1912.834% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -689.233% |
| HilleVax, Inc. | -165.48 Million USD | 20.392% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -5090.701% |
| Tharimmune, Inc. | -10.93 Million USD | -1104.717% |
| Genprex, Inc. | -6.73 Million USD | -1855.287% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 64.279% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -48.926% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -9303.283% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -3871.726% |
| OKYO Pharma Limited | -826.84 Thousand USD | -15832.795% |
| Savara Inc. | 153 Thousand USD | 86204.575% |
| Curis, Inc. | -23.88 Million USD | -451.513% |
| Daré Bioscience, Inc. | -5.15 Million USD | -2454.135% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -16876.541% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -2022.1% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 11217.299% |
| BeiGene, Ltd. | -2.25 Billion USD | 94.153% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1167.715% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 78.34% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 29.014% |
| Erasca, Inc. | -37.21 Million USD | -253.988% |
| bluebird bio, Inc. | 108.57 Million USD | 221.34% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -10129.111% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 134.783% |
| DBV Technologies S.A. | -126.98 Million USD | -3.744% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -10129.111% |
| Moderna, Inc. | -2.9 Billion USD | 95.468% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1172.604% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1112.183% |
| Molecular Templates, Inc. | 707 Thousand USD | 18733.663% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -319.942% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 138.008% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -60.537% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -43.617% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -308.218% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -283.232% |
| MacroGenics, Inc. | -66.98 Million USD | -96.671% |
| RenovoRx, Inc. | -1.17 Million USD | -11131.031% |
| Adicet Bio, Inc. | -138.78 Million USD | 5.078% |
| Prime Medicine, Inc. | -27.94 Million USD | -371.494% |
| Aditxt, Inc. | 18.12 Million USD | 827.006% |
| Adagene Inc. | -87.62 Million USD | -50.341% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3062.7% |
| Quantum-Si incorporated | -118.55 Million USD | -11.12% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 465.894% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -1662.599% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -171.578% |
| SciSparc Ltd. | -2.06 Million USD | -6279.661% |
| Vericel Corporation | 1.27 Million USD | 10416.366% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -998.593% |
| Minerva Neurosciences, Inc. | 41 Million USD | 421.284% |
| Generation Bio Co. | 31.44 Million USD | 518.914% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 24.876% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -326.026% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 212.991% |
| Invivyd, Inc. | -198.47 Million USD | 33.624% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -45.94% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -5394.459% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -86.1% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -1830.256% |
| 2seventy bio, Inc. | 181.71 Million USD | 172.498% |
| ADMA Biologics, Inc. | 90.06 Million USD | 246.271% |
| Clene Inc. | 3.34 Million USD | 4044.311% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1350.449% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -512.431% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1941.661% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 61.717% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -406.698% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 174.15% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -3119.793% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 2733.746% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -2429.084% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -1.102% |
| Evaxion Biotech A/S | 5.28 Million USD | 2591.846% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -17.031% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -0.356% |
| Trevena, Inc. | 2.25 Million USD | 5934.367% |
| Surrozen, Inc. | -32.66 Million USD | -303.319% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -155.756% |
| Cingulate Inc. | 3.08 Million USD | 4373.55% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -4385.529% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 1933.032% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1317.897% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -66.08% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -0.219% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -24.822% |
| Clearmind Medicine Inc. | -3.94 Million USD | -3241.418% |
| Kronos Bio, Inc. | -36.05 Million USD | -265.396% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1500.149% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 9134.878% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -142.812% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1013.82% |
| ImmunityBio, Inc. | 618.22 Million USD | 121.309% |
| Korro Bio, Inc. | -132.94 Million USD | 0.905% |
| Kineta, Inc. | -4.54 Million USD | -2801.123% |
| BioVie Inc. | -17.73 Million USD | -642.936% |
| Codexis, Inc. | -43.27 Million USD | -204.453% |
| Celularity Inc. | 65.19 Million USD | 302.086% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -4057.147% |
| Celcuity Inc. | 6.78 Million USD | 2042.063% |
| Virax Biolabs Group Limited | -3.36 Million USD | -3815.073% |
| Cibus, Inc. | -8.07 Million USD | -1530.849% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -3015.157% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 2982.713% |
| IN8bio, Inc. | -16.38 Million USD | -703.832% |
| Kodiak Sciences Inc. | -103.87 Million USD | -26.826% |
| Annexon, Inc. | -193.75 Million USD | 32.007% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 366044.442% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -652.843% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -3650.071% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 112.496% |
| Eyenovia, Inc. | 1.25 Million USD | 10566.337% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 589.649% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -3962.288% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -296.246% |
| Arcellx, Inc. | -296.95 Million USD | 55.637% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -575.382% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -123.762% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -535.596% |
| Moolec Science SA | 117.61 Thousand USD | 112108.569% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -243.082% |
| Geron Corporation | 14.76 Million USD | 992.487% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -247.434% |
| Royalty Pharma plc | 5.65 Billion USD | 102.328% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 6.846% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -1784.848% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -2356.526% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 6.389% |
| Humacyte, Inc. | -22.48 Million USD | -485.876% |
| Structure Therapeutics Inc. | -124.33 Million USD | -5.952% |
| 89bio, Inc. | -289.05 Million USD | 54.424% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -421.908% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -7288.671% |
| Genelux Corporation | -6.89 Million USD | -1809.552% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -324.16% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 257.586% |
| Notable Labs, Ltd. | -9.77 Million USD | -1247.586% |
| Liquidia Corporation | -80.17 Million USD | -64.314% |
| Mustang Bio, Inc. | -3.73 Million USD | -3426.231% |
| Immunovant, Inc. | -635.22 Million USD | 79.261% |
| Quantum-Si incorporated | -118.55 Million USD | -11.12% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -650.057% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -3079.821% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 1741.211% |
| Acasti Pharma Inc. | -23 Million USD | -472.658% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -3812.416% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -710.739% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 4.356% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -4127.365% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -492.569% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -609.462% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 22.175% |
| PepGen Inc. | -60.67 Million USD | -117.142% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -473.381% |
| United Therapeutics Corporation | -507.7 Million USD | 74.052% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -588.801% |
| Solid Biosciences Inc. | -47.75 Million USD | -175.895% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -15181.485% |
| Immuneering Corporation | -54.94 Million USD | -139.776% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3034.064% |
| Silo Pharma, Inc. | -3.52 Million USD | -3638.039% |
| Belite Bio, Inc | -87.27 Million USD | -50.955% |
| XOMA Corporation | -29 Million USD | -354.276% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -86.345% |
| Bionomics Limited | 227 Million USD | 158.033% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -13.294% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -5100.947% |
| uniQure N.V. | -102.95 Million USD | -27.964% |
| Cassava Sciences, Inc. | -121.13 Million USD | -8.754% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3062.7% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 421.702% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1001.413% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -4157.643% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 124383.018% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -3962.288% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1579.394% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -1676.429% |
| Altimmune, Inc. | -134.48 Million USD | 2.043% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 166.514% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -5100.947% |
| Compugen Ltd. | -12.9 Million USD | -920.924% |
| Peak Bio, Inc. | 10.34 Million USD | 1374.062% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -46451.236% |
| Benitec Biopharma Inc. | -50.58 Million USD | -160.448% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -26.263% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 770.603% |
| Zura Bio Limited | -99.8 Million USD | -31.996% |
| PolyPid Ltd. | 6.17 Million USD | 2235.17% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 277.739% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 770.603% |
| Instil Bio, Inc. | 75.35 Million USD | 274.819% |
| argenx SE | -2.02 Billion USD | 93.507% |
| Immunome, Inc. | -97.02 Million USD | -35.774% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -485.641% |
| Verona Pharma plc | -220.44 Million USD | 40.239% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -83.628% |
| Shattuck Labs, Inc. | -121.42 Million USD | -8.496% |
| CervoMed Inc. | -7.79 Million USD | -1590.525% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 28.981% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -2912.577% |
| Moolec Science SA | 117.61 Thousand USD | 112108.569% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -5657.925% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 928.638% |
| AnaptysBio, Inc. | -18.15 Million USD | -625.8% |
| Design Therapeutics, Inc. | -18.15 Million USD | -625.84% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -87.181% |
| NeurAxis, Inc. | 145.7 Thousand USD | 90518.668% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1272.899% |
| Lumos Pharma, Inc. | -28.49 Million USD | -362.359% |
| Achilles Therapeutics plc | -126.92 Million USD | -3.794% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -83.628% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -19990.586% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -534.163% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 9134.878% |
| Nutriband Inc. | -251.65 Thousand USD | -52249.03% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -900.228% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -1670.699% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 138.725% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 655.045% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 70.559% |
| Palisade Bio, Inc. | -12.06 Million USD | -992.1% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 6.109% |
| Beam Therapeutics Inc. | -262.72 Million USD | 49.856% |
| Neurogene Inc. | -131.95 Million USD | 0.163% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 703.869% |
| AEON Biopharma, Inc. | -4.88 Million USD | -2599.59% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 65.073% |
| Sesen Bio, Inc. | -112.55 Million USD | -17.047% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -31.925% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -5511.227% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -237.57% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -58.185% |
| Athira Pharma, Inc. | -88.99 Million USD | -48.024% |
| Vaccinex, Inc. | -1.28 Million USD | -10128.261% |
| HCW Biologics Inc. | 2.85 Million USD | 4711.654% |
| XOMA Corporation | -29 Million USD | -354.276% |
| Nektar Therapeutics | 210.24 Million USD | 162.662% |
| Arvinas, Inc. | -313.8 Million USD | 58.018% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 8217.617% |
| Merus N.V. | -192.88 Million USD | 31.7% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 319.622% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -1798.818% |
| Rezolute, Inc. | -68.16 Million USD | -93.258% |
| Clene Inc. | 3.34 Million USD | 4044.311% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -899.014% |
| BeyondSpring Inc. | -13.75 Million USD | -857.761% |
| Synlogic, Inc. | -6.68 Million USD | -1870.681% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 11717.284% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1458.131% |
| Peak Bio, Inc. | 10.34 Million USD | 1374.062% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -59.84% |
| Krystal Biotech, Inc. | -350.23 Million USD | 62.385% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 206.135% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 22.045% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -4072.759% |
| MannKind Corporation | 143.89 Million USD | 191.55% |
| Ikena Oncology, Inc. | -109.15 Million USD | -20.69% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -1640.061% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -298.006% |
| Gossamer Bio, Inc. | 180.35 Million USD | 173.045% |
| CohBar, Inc. | -5.93 Million USD | -2121.311% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -342.853% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2985.239% |
| Legend Biotech Corporation | -949.39 Million USD | 86.124% |
| Mural Oncology plc | -255.84 Million USD | 48.507% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 508.94% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -2696.646% |
| Disc Medicine, Inc. | -358.28 Million USD | 63.23% |
| Champions Oncology, Inc. | 4.81 Million USD | 2837.739% |
| REGENXBIO Inc. | 54.76 Million USD | 340.542% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -48890.915% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 12.769% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1361.828% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -63.281% |
| Vaxart, Inc. | -8.24 Million USD | -1498.592% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -162.535% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -3.597% |
| Cellectis S.A. | -43.85 Million USD | -200.399% |
| Longeveron Inc. | -2.9 Million USD | -4430.261% |
| Repare Therapeutics Inc. | -107.85 Million USD | -22.142% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 113.604% |
| Inozyme Pharma, Inc. | 12 Million USD | 1197.468% |
| Revolution Medicines, Inc. | -608.2 Million USD | 78.34% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -10610.569% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 50.309% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 12.215% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -741.951% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -17702.703% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.623% |
| Denali Therapeutics Inc. | -74.86 Million USD | -75.97% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -998.593% |
| Veru Inc. | 4.77 Million USD | 2856.085% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1071.439% |
| Cingulate Inc. | 3.08 Million USD | 4373.55% |
| Passage Bio, Inc. | 4.58 Million USD | 2973.282% |
| Context Therapeutics Inc. | -14.44 Million USD | -811.706% |
| Exicure, Inc. | 5.84 Million USD | 2352.351% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 42.815% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -232.929% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 939.59% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -123.968% |
| Nuvalent, Inc. | -335.38 Million USD | 60.72% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 7695.969% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -76.875% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1381.89% |
| OmniAb, Inc. | 9.2 Million USD | 1531.49% |
| Anew Medical, Inc. | 1.43 Million USD | 9296.734% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 904.187% |
| Lipocine Inc. | -4.75 Million USD | -2670.795% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -19.951% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 964.946% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -160.052% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 629.246% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -1860.125% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -100.131% |
| Ocugen, Inc. | -32.52 Million USD | -305.092% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -53.947% |
| Q32 Bio Inc. | -37.94 Million USD | -247.159% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -20877.707% |
| Alumis Inc. Common Stock | -13.52 Million USD | -873.76% |
| Equillium, Inc. | -22.39 Million USD | -488.335% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -415.253% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -303.779% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -53039.18% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 198.283% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 4219.45% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 40210.705% |
| Dominari Holdings Inc. | 195 Thousand USD | 67658.974% |
| Edesa Biotech, Inc. | -5.26 Million USD | -2401.277% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1377.403% |
| Bio-Techne Corporation | 267.74 Million USD | 149.203% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -712.758% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -11.555% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1467.773% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -941.341% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 46.255% |
| Nkarta, Inc. | 57.29 Million USD | 329.917% |
| BioCardia, Inc. | 212 Thousand USD | 62241.509% |
| Iterum Therapeutics plc | 13.43 Million USD | 1080.354% |